RSV vaccine could cut baby hospital admissions by more than 80%, study suggests

'Game-changing' RSV jab to protect babies 'could cut hospitalisations by 83%'

A JAB protecting babies from a sometimes-deadly winter virus could slash hospitalisations from it by more than 80 per cent, a trial has shown. Respiratory syncytial virus (RSV) is an incredibly common virus that most children will pick up before the age of two, often causing mild, cold-like illnesses. Getty Images - GettyScientists estimate that a game-changing jab could slash RSV-hospitalisations by 83 per cent[/caption] It typically circula…

New vaccine for winter virus common in babies could 'dramatically' cut hospital admissions

A vaccine to combat a common seasonal virus among babies could reduce hospital admissions by more than 80%, a trial has shown.

Winter virus jab for babies ‘can cut RSV-related hospital admissions by 83pc,’ trial shows

A winter virus jab for babies could ease the burden on the NHS in the UK, scientists have said, after a large clinical trial has shown it can reduce related hospital admissions by more than 80pc.

Vaccine could cut RSV hospital admissions in babies by 80%, study finds

International research indicates giving infants nirsevimab would cause sharp drop in rates of respiratory syncytial virus infection A vaccine could reduce by 80% the numbers of babies and young children admitted to hospital with respiratory syncytial virus (RSV), a “groundbreaking” study has found.The study, published in the peer-reviewed New England Journal of Medicine, involved 8,058 healthy babies aged up to 12 months from the UK, France and …

RSV: Jab for winter virus could cut baby hospitalisations by 80%, study says

More than 30,000 UK children under five are hospitalised with respiratory syncytial virus a year.

Winter virus jab for babies ‘can cut RSV-related hospital admissions by 83%’

The treatment could help ease seasonal pressures on the NHS, researchers said.